Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis
2015 · Alimentary Pharmacology & Therapeutics · 133 citations
https://doi.org/10.1111/apt.13353
P
Peter De Cruz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
330
Papers
6.3K
Citations
39
h-index
91
i10-index
Peter De Cruz is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Liver Diseases and Immunity. The author has an h-index of 39, co-authored 281 publications.
ORCID: 0000-0002-3399-7236Papers by this author
worksDevelopment and validation of a patient‐reported disability measurement tool for patients with <scp>inflammatory bowel disease</scp>
2012 · Alimentary Pharmacology & Therapeutics · 42 citations
https://doi.org/10.1111/apt.12187
Examining barriers to care: Provider and client perspectives on the stigmatization of HIV-positive Asian Americans with and without viral hepatitis co-infection
2012 · AIDS Care · 25 citations
https://doi.org/10.1080/09540121.2012.658756
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
2020 · World Journal of Gastroenterology · 21 citations
https://doi.org/10.3748/wjg.v26.i30.4428
BECLIN1 is essential for intestinal homeostasis involving autophagy-independent mechanisms through its function in endocytic trafficking
2024 · Communications Biology · 21 citations
https://doi.org/10.1038/s42003-024-05890-7
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis
2023 · Inflammatory Bowel Diseases · 12 citations
https://doi.org/10.1093/ibd/izad183
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat